Norwegian Cruise Line rang the opening bell at the New York Stock Exchange in celebration of the fifth anniversary of its IPO. Frank Del Rio, President & CEO of Norwegian Cruise Line, was with us to share which milestones stand out to him the most.
Del Rio highlights the consistent growth in the company. One milestone that he is most proud of is Norwegian’s acquisition of Prestige Holdings, which he founded. Revenue for the company jumped 11% since last year and doubled since the IPO. He says Norwegian is a story of organic growth and he sees it continuing.
China has been a tough market to crack for many U.S. companies, but not for Norwegian. Del Rio says the company found success by thinking about what the Chinse consumer wants. He says they love to shop for luxury brands, so the company built the ship with 60% more retail space. Additionally, Norwegian capitalized on gaming by putting 3 casinos on board. On top of that, he says Chinese consumers aren't big sunbathers, so the company deemphasized the pool deck.
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
